LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP6 | 3 | I03 | 72 | hr | 1311 | 889 | 4973 | 0.1787 | -0.1832 |
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP5 | 1 | D03 | 72 | hr | 1311 | 1003 | 5128 | 0.1956 | -0.1275 |
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP5 | 2 | D03 | 72 | hr | 1311 | 880 | 5100 | 0.1726 | -0.1843 |
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP5 | 3 | D03 | 72 | hr | 1311 | 969 | 5010 | 0.1934 | -0.1450 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP6 | 1 | I02 | 72 | hr | 1311 | 891 | 4870 | 0.1830 | -0.1848 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP6 | 2 | I02 | 72 | hr | 1311 | 923 | 4961 | 0.1860 | -0.1673 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP6 | 3 | I02 | 72 | hr | 1311 | 810 | 4973 | 0.1629 | -0.2217 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP5 | 1 | D02 | 72 | hr | 1311 | 934 | 5128 | 0.1821 | -0.1586 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP5 | 2 | D02 | 72 | hr | 1311 | 972 | 5100 | 0.1906 | -0.1419 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP5 | 3 | D02 | 72 | hr | 1311 | 964 | 5010 | 0.1924 | -0.1473 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP6 | 1 | I01 | 72 | hr | 1311 | 708 | 4870 | 0.1454 | -0.2781 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP6 | 2 | I01 | 72 | hr | 1311 | 734 | 4961 | 0.1479 | -0.2610 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP6 | 3 | I01 | 72 | hr | 1311 | 590 | 4973 | 0.1186 | -0.3400 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP5 | 1 | D01 | 72 | hr | 1311 | 1115 | 5128 | 0.2174 | -0.0793 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP5 | 2 | D01 | 72 | hr | 1311 | 1059 | 5100 | 0.2077 | -0.1035 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP5 | 3 | D01 | 72 | hr | 1311 | 1067 | 5010 | 0.2129 | -0.1013 |
MDA-MB-231 | Tozasertib | 0.04 | uM | LJP5 | 1 | B18 | 72 | hr | 1311 | 1397 | 5128 | 0.2724 | 0.0325 |
MDA-MB-231 | Tozasertib | 0.04 | uM | LJP5 | 2 | B18 | 72 | hr | 1311 | 1655 | 5100 | 0.3245 | 0.1260 |
MDA-MB-231 | Tozasertib | 0.04 | uM | LJP5 | 3 | B18 | 72 | hr | 1311 | 1428 | 5010 | 0.2850 | 0.0449 |
MDA-MB-231 | Tozasertib | 0.12 | uM | LJP5 | 1 | B17 | 72 | hr | 1311 | 1352 | 5128 | 0.2636 | 0.0155 |
MDA-MB-231 | Tozasertib | 0.12 | uM | LJP5 | 2 | B17 | 72 | hr | 1311 | 1495 | 5100 | 0.2931 | 0.0690 |
MDA-MB-231 | Tozasertib | 0.12 | uM | LJP5 | 3 | B17 | 72 | hr | 1311 | 1298 | 5010 | 0.2590 | -0.0054 |
MDA-MB-231 | Tozasertib | 0.37 | uM | LJP5 | 1 | B16 | 72 | hr | 1311 | 1401 | 5128 | 0.2732 | 0.0340 |
MDA-MB-231 | Tozasertib | 0.37 | uM | LJP5 | 2 | B16 | 72 | hr | 1311 | 1611 | 5100 | 0.3159 | 0.1106 |
MDA-MB-231 | Tozasertib | 0.37 | uM | LJP5 | 3 | B16 | 72 | hr | 1311 | 1395 | 5010 | 0.2784 | 0.0323 |